Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors

Neuroscience Research

Volumn 54, Issue 4, 2006, Pages 288-294

  Hirate, Kenji ^a   Uchida, Aoi ^a   Ogawa, Yuki ^a   Arai, Tomoko ^b   Yoda, Kentaro ^b  

^a Nippon Chemiphar Co Ltd   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Acetic acid; Bradykinin; Dorsal root ganglion; Nociceptive response; NSAIDs; Zaltoprofen

Indexed keywords

ACETIC ACID; BRADYKININ; CALCIUM; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETODOLAC; INDOMETACIN; LOXOPROFEN; MELOXICAM; MOFEZOLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; ZALTOPROFEN;

ANALGESIA; ANIMAL MODEL; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME INHIBITION; LIGAND BINDING; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL GANGLION; WRITHING TEST;

ACETIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOPYRANS; BRADYKININ; CALCIUM; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; GANGLIA, SPINAL; GUINEA PIGS; MALE; MICE; MICE, INBRED ICR; PAIN; PROPIONIC ACIDS; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 33644870952     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2005.12.016     Document Type: Article

References (33)

1. J.W. Berkenkopf, and B.M. Weichman Production of prostacyclin in mice following intraperitoneal injection of acetic acid, phenylbenzoquinone and zymosan: its role in the writhing response Prostaglandins 36 5 1988 693 709
2. C. Blais Jr., A. Adams, D. Massicotte, and F.J. Peronnet Increase in blood bradykinin concentration after eccentric weight-training exercise in men J. Appl. Physiol. 87 3 1999 1197 1201
3. H.H. Chuang, E.D. Prescott, H. Kong, S. Shields, S.E. Jordt, A.I. Basbaum, M.V. Chao, and D. Julius Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition Nature 41 2004 957 962
4. R. Deraedt, S. Jouquey, F. Delevallee, and M. Flahaut Release of prostaglandins E and F in algogenic reaction and its inhibition Eur. J. Pharmacol. 61 1 1980 17 24
5. J. Ferreira, G.L. da Silva, and J.B. Calixto Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice Br. J. Pharmacol. 141 2004 787 794
6. T. Graven-Nielsen, and S. Mense The peripheral apparatus of muscle pain: evidence from animal and human studies Clin. J. Pain 17 1 2001 2 10
7. K.M. Hargreaves, M.T. Roszkowski, and J.Q. Swift Bradykinin and inflammatory pain Agents Actions Suppl. 41 1993 65 73
8. Y. Ikeda, A. Ueno, H. Naraba, and S. Oh-ishi Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing response in mice Life Sci. 69 24 2001 2911 2919
9. M. Inoue, and H. Ueda Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice J. Pharmacol. Exp. Ther. 293 2000 662 669
10. D. Julius, and A.I. Basbaum Molecular mechanisms of nociception Nature 413 2001 203 210
11. T. Kameyama, T. Nabeshima, S. Yamada, and M. Sato Analgesic and antiinflammatory effects of 2-(10,11-dihydro-10-oxodibenzo[b, f]thiepin-2-yl) propionic acid in rat and mouse Arzneim- Forsch/Drug Res. 37 1 1987 19 26
12. Y. Komatsubara, R. Ogawa, A. Ueyoshi, O. Akabori, T. Doi, and S. Kitabatake Evaluation of the efficacy of CN-100 for relief of post-operative and post-traumatic pain and inflammation Jpn. Pharmacol. Ther. 19 4 1991 1545 1565
13. T. Kunigami, A. Uchida, K. Nishioka, K. Hirate, and T. Saitoh Selective prostaglandin biosynthesis inhibition of zaltoprofen at the inflammatory site Inflammation Regeneration 21 3 2001 235 241
14. Y. Kuzuoka, J. Ohtani, K. Suzuki, M. Sakakibara, and K. Yoda Excitation of cultured dorsal root ganglion neurons by algesic substances and its suppression with low-power laser irradiation J. Adv. Sci. 12 2000 7 11
15. H. Matsumoto, H. Naraba, A. Ueno, T. Fujiyoshi, M. Murakami, I. Kudo, and S. Oh-ishi Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice Eur. J. Pharmacol. 352 1 1998 47 52
16. K. Mizumura, M. Minagawa, Y. Tsujii, and T. Kumazawa The effects of bradykinin agonist and antagonists on visceral polymodal receptor activities Pain 40 1990 221 227
17. H. Mork, M. Ashina, L. Bendtsen, J. Olesen, and R. Jensen Experimental muscle pain and tenderness following infusion of endogenous substances in humans Eur. J. Pain 7 2 2003 145 153
18. T. Muratani, Y. Doi, W. Nishimura, M. Nishimura, T. Minami, and S. Ito Preemptive analgesia by zaltoprofen in a mouse model of post-operative pain through blockade of the bradykinin B2 pathway Neurosci. Res. 51 4 2005 427 433
19. K. Nishioka, A. Uchida, M. Kunigami, H. Matsukura, K. Hirate, and T. Saitoh Relationship between selective COX-2 inhibition and tissue selectivity of prostaglandin biosynthesis inhibition of zaltoprofen Jap. J. Inflammation 20 3 2000 247 255
20. K. Noda, Y. Ueda, K. Suzuki, and K. Yoda Excitatory effects of algesic compounds on neuronal processes in murine dorsal root ganglion cell culture Brain Res. 751 1997 348 351
21. G.N. Prado, L. Taylor, X. Zhou, D. Ricupero, D.F. Mierke, and P. Polgar Mechanisms regulating the expression, self-maintenance and signaling-function of the bradykinin B2 and B1 receptors J. Cell Physiol. 193 2002 275 286
22. L.S. Premkumar, and G.P. Ahern Induction of vanilloid receptor channel activity by protein kinase C Nature 408 6815 2000 985 990
23. M.H. Rashid, M. Inoue, M. Matsumoto, and H. Ueda Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice J. Pharmacol. Exp. Ther. 308 2004 1158 1164
24. M.H. Rashid, M. Inoue, and H. Ueda Selective antagonistic effect for B2 receptor-mediated nociception by zaltoprofen, a non-steroidal anti-inflammatory drug 11th International Pain Clinic World Society of Pain Clinicians 2004 134 135
25. J.H. Sharma, and W.W. Buchanan Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease Exp. Toxic Pathol. 46 1994 421 433
26. J. Shin, H. Cho, S.W. Hwang, J. Jung, C.Y. Shin, S.Y. Lee, S.H. Kim, M.G. Lee, Y.H. Choi, J. Kim, N.A. Haber, D.B. Reichling, S. Khasar, J.D. Levine, and U. Oh Bradykinin-12-lipoxygenase-vanilloid receptor 1 signaling pathway for inflammatory hyperalgesia Proc. Natl. Acad. Sci. U.S.A. 99 2002 10150 10155
27. T. Sugiura, M. Tominaga, H. Kasuya, and K. Mizumura Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1 J. Neurophysiol. 88 1 2002 544 548
28. H.B. Tang, A. Inoue, K. Oshita, and Y. Nakata Sensitization of vanilloid receptor 1 induced by bradykinin via the activation of second messenger signaling cascades in rat primary afferent neurons Eur. J. Pharmacol. 498 2004 37 43
29. H.-B. Tang, A. Inoue, K. Oshita, K. Hirate, and Y. Nakata Zaltoprofen inhibits bradykinin-induced responses by blocking the activation of second messenger signaling cascades in rat dorsal root ganglion cells Neuropharmacology 48 2005 1035 1042
30. K. Tsurumi, K. Kyuki, M. Niwa, S. Kokuba, and H. Fujimura Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10- oxodibenzo[b, f] thiepin-2-yl) propionic acid. 1st communication: inhibitory effects of rat paw edema Arzneim- Forsch/Drug Res. 36 12 1986 1796 1800
31. K. Tsurumi, K. Kyuki, M. Niwa, H. Mibu, and H. Fujimura Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10- oxodibenzo[b, f] thiepin-2-yl) propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions Arzneim- Forsch/Drug Res. 36 12 1986 1801 1805
32. H. Vanegas, and H.G. Schaible Prostaglandins and cyclooxygenases in the spinal cord Prog. Neurobiol. 64 2001 327 363
33. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 2 1983 109 110